High-dose primaquine regimens against relapse of Plasmodium vivax malaria.

Abstract

Plasmodium vivax causes debilitating but usually non-lethal malaria in most of Asia and South America. Prevention of relapse after otherwise effective therapy for the acute attack requires a standard daily dose of primaquine administered over 14 days. This regimen has < 90% efficacy in Thailand, and is widely regarded as ineffective because of poor… (More)

4 Figures and Tables

Topics

  • Presentations referencing similar topics